Sort
39,280 grants matching “leukemia”
Kmt2a/MLL1 regulation of endothelial activation
$607,566Andrea Tara Obi · University Of Michigan At Ann Arbor · R01 · FY2024 · HL
Uncovering the role for MSI2 network in hematopoietic stem cells
$607,423Michael Kharas · Sloan-Kettering Inst Can Research · R01 · FY2024 · DK
The role of HPF1 in radiation and genotoxic cancer therapy
$607,194Shan Zha · Columbia University Health Sciences · R01 · FY2025 · CA
Targeting RAS in Pediatric Cancer
$607,140Marielle Yohe · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
TARGETING LEUKEMIA-INITIATING CELLS TO IMPROVE LEUKEMIA TREATMENT
$607,046Trustees Of Indiana University · · FY2019 · Department of the Army
Gene Regulation By Steroid Receptor Proteins
$607,002Keith Robert Yamamoto · University Of California, San Francisco · R01 · FY2012 · CA
Promoting Treatment Adherence in Adolescent Leukemia
$606,742Dennis D Drotar · Cincinnati Childrens Hosp Med Ctr · R01 · FY2011 · CA
Cancer Genomics
$606,597Thomas Ried · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
Gene Therapy for Human Malignant Melanoma
$606,567Introgen Therapeutics, Inc. · R42 · FY2004 · CA
Modeling and correcting human SCID using patient-derived iPS cells
$606,518Luigi Daniele Notarangelo · Boston Children'S Hospital · R01 · FY2012 · AI
Comprehensive Approach to Improve Medicine Adherence in Pediatric Leukmia
$606,475Smita Bhatia · University Of Alabama At Birmingham · R01 · FY2017 · CA
Impact of low IL-10 levels at birth and leukemia risk
$606,390Scott C Kogan · University Of California, San Francisco · R01 · FY2017 · CA
Dissecting innate immune signaling in pre-leukemia evolution
$606,333Daniel Starczynowski · Cincinnati Childrens Hosp Med Ctr · R01 · FY2024 · CA
Towards Safer and More Effective CART Cell Therapy Through the Modulation of Myeloid Cytokines
$606,332Saad J. Kenderian · Mayo Clinic Rochester · R37 · FY2022 · CA
Development of ESP: Structural &Functional Oncogenomics
$606,330University Of California San Francisco · R33 · FY2004 · CA
Clinical Trials with Immunotoxins
$606,310Ira Pastan · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Small-molecule degraders of BET proteins
$606,297Shaomeng Wang · University Of Michigan At Ann Arbor · R01 · FY2020 · CA
Microbiota-focused strategies to mitigate GVHD
$606,287Robert Jenq · Sloan-Kettering Inst Can Research · R01 · FY2015 · HL
Socioeconomic determinants of childhood cancer outcomes in a large contemporary cohort
$606,039Erin Marcotte · University Of Minnesota · R01 · FY2024 · CA
An Integrated Approach for Computationally Designing and Experimentally Characterizing Fully-Human Antibodies
$606,000Costas D Maranas · Pennsylvania State Univ University Park · · FY2012 · ENG
Mechanisms of epitranscriptomic regulation in cancer
$605,929Samie R Jaffrey · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
CHEMOTHERAPY DECISIONS AND OUTCOMES FOR THE ELDERLY
$605,762Georgetown University · U10 · FY2001 · CA
Development and Plasticity of Neural Circuits Underlying Sound Encoding
$605,722Brikha Raj Shrestha · Massachusetts Eye And Ear Infirmary · R01 · FY2025 · DC
Biochemistry of Leukemia Virus Core-Binding Factor
$605,717Nancy Asmussen Speck · University Of Pennsylvania · R01 · FY2024 · HL
Retrovirus Biology
$605,678Alan Rein · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA